Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lipson

Showing results (181-190 of 249) with videos related to

Pageof 25
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 5, 2017
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine|September 27, 2017
Reply to Suissa and Ariel: The FULFIL TrialDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2017
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
Journal of Surgical Oncology|July 11, 2024
Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT frameworkLindsay K Dickerson, Trisha A Lipson, Sardar Shahmir B Chauhan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipientVivek N Ahya, Alden M Doyle, James D Mendez, et al.
COPD|September 29, 2018
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)Jinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
Journal of Breast Imaging|February 10, 2026
Diagnostic Axillary US: How Indication and Breast Cancer Status Impact Diagnostic OutcomesHoward Z Yan, Tie Liang, Wendy B DeMartini, et al.
Current Medical Research and Opinion|October 30, 2020
Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trialJinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
American Journal of Respiratory and Critical Care Medicine|January 3, 2006
Risk factors for death of patients with cystic fibrosis awaiting lung transplantationRichard A Belkin, Noreen R Henig, Lianne G Singer, et al.
Therapeutic Advances in Respiratory Disease|November 10, 2020
Impact of baseline COPD symptom severity on the benefit from dual <i>versus</i> mono-bronchodilators: an analysis of the EMAX randomised controlled trialClaus F Vogelmeier, Edward M Kerwin, Leif H Bjermer, et al.
Pageof 25

Showing results (181-190 of 249) with videos related to

Sort By:
Pageof 25
American Journal of Respiratory and Critical Care Medicine|April 5, 2017
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine|September 27, 2017
Reply to Suissa and Ariel: The FULFIL TrialDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2017
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Helen Barnacle, Ruby Birk, et al.
Journal of Surgical Oncology|July 11, 2024
Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT frameworkLindsay K Dickerson, Trisha A Lipson, Sardar Shahmir B Chauhan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipientVivek N Ahya, Alden M Doyle, James D Mendez, et al.
COPD|September 29, 2018
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)Jinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
Journal of Breast Imaging|February 10, 2026
Diagnostic Axillary US: How Indication and Breast Cancer Status Impact Diagnostic OutcomesHoward Z Yan, Tie Liang, Wendy B DeMartini, et al.
Current Medical Research and Opinion|October 30, 2020
Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trialJinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
American Journal of Respiratory and Critical Care Medicine|January 3, 2006
Risk factors for death of patients with cystic fibrosis awaiting lung transplantationRichard A Belkin, Noreen R Henig, Lianne G Singer, et al.
Therapeutic Advances in Respiratory Disease|November 10, 2020
Impact of baseline COPD symptom severity on the benefit from dual <i>versus</i> mono-bronchodilators: an analysis of the EMAX randomised controlled trialClaus F Vogelmeier, Edward M Kerwin, Leif H Bjermer, et al.
Pageof 25